ProShares UltraShort Health Care (J409)

Overview

The fund described is managed by ProShare Advisors, focusing on leveraging financial instruments to meet a specified daily target return. This target is strategically achieved through investments across a diversified portfolio within the healthcare and life sciences sectors. Covering a broad spectrum from health care equipment & supplies to biotechnology and pharmaceuticals, the fund aims to capitalize on the growth and innovation within these industries. It's important to note that despite its expansive coverage, the fund is characterized as non-diversified, meaning it may concentrate its investments in fewer individual holdings than a diversified fund. This strategy is intended for investors looking for daily targeted returns, aligning with the dynamic and critical nature of the healthcare and life sciences sectors.

Products and Services

The fund offers a focused investment approach in the healthcare and life sciences sectors through the following vehicles:

• Health Care Equipment & Supplies: Investments in companies that manufacture and distribute medical devices and supplies. This includes a wide range of products necessary for the diagnosis, treatment, and monitoring of diseases and conditions, reflecting the sector's potential for innovation and growth.
• Health Care Providers & Services: Coverage of entities that offer medical services directly or indirectly to patients. This broad category includes hospitals, clinics, and possibly health insurance companies, emphasizing the fund's investment in healthcare delivery and services.
• Health Care Technology: Inclusion of companies at the intersection of technology and health care. This area encompasses medical software, telehealth, and other digital health solutions, marking the fund's commitment to technological advancements in healthcare.
• Biotechnology: Focus on companies engaged in the research and development of therapeutic and diagnostic solutions based on biological mechanisms. This sector is recognized for its high growth potential driven by scientific breakthroughs and innovation.
• Pharmaceuticals: Investment in companies involved in the discovery, development, and marketing of drugs and therapies. This pivotal segment of the healthcare market offers potential returns from both established and emerging companies working on groundbreaking treatments.
• Life Sciences Tools & Services: Backing of enterprises providing products and services essential for scientific research, such as lab instruments and supplies. This area underscores the fund's strategy to support the foundational elements of healthcare innovation.